跳至主導覽 跳至搜尋 跳過主要內容

Hypoxia, epithelial-mesenchymal transition, and tet-mediated epigenetic changes

  • Shih Han Kao
  • , Kou Juey Wu*
  • , Wen Hwa Lee
  • *此作品的通信作者
  • China Medical University Taichung

研究成果: 期刊稿件 › 文獻綜述 › 同儕審查

57 引文 斯高帕斯(Scopus)

摘要

Tumor hypoxia is a pathophysiologic outcome of disrupted microcirculation with inadequate supply of oxygen, leading to enhanced proliferation, epithelial-mesenchymal transition (EMT), metastasis, and chemo-resistance. Epigenetic changes induced by hypoxia are well documented, and they lead to tumor progression. Recent advances show that DNA demethylation mediated by the Ten-eleven translocation (TET) proteins induces major epigenetic changes and controls key steps of cancer development. TET enzymes serve as 5mC (5-methylcytosine)-specific dioxygenases and cause DNA demethylation. Hypoxia activates the expression of TET1, which also serves as a co-activator of HIF-1a transcriptional regulation to modulate HIF-1a downstream target genes and promote epithelial-mesenchymal transition. As HIF is a negative prognostic factor for tumor progression, hypoxia-activated prodrugs (HAPs) may provide a favorable therapeutic approach to lessen hypoxia-induced malignancy.

原文英語
文章編號24
期刊Journal of Clinical Medicine
卷5
發行號2
DOIs
出版品狀態已出版 - 04 02 2016
對外發佈是

文獻附註

Publisher Copyright:
© 2016 by the authors; licensee MDPI, Basel, Switzerland.

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Hypoxia, epithelial-mesenchymal transition, and tet-mediated epigenetic changes」主題。共同形成了獨特的指紋。

引用此